Yıl: 2021 Cilt: 32 Sayı: 2 Sayfa Aralığı: 218 - 224 Metin Dili: İngilizce DOI: 10.5152/tjg.2021.20334 İndeks Tarihi: 02-06-2022

Routine Histopathological Examination of the Specimen After Laparoscopic Cholecystectomy: Can We Be Brave Enough to Give Up?

Öz:
Background: Selective versus routine histopathological examination after cholecystectomy is still in debate. This study aims to investigate the effect of histopathology results on treatment modality and surgery strategy. The validity of the selective histopathology approach was questioned. Methods: The data of patients undergoing laparoscopic cholecystectomy between January 2009 and December 2019 were retrospectively analyzed. The demographics and histopathology results, whether the operation was emergent or elective, and the reasons for conversion to open surgery were recorded. Malignant and precursor histopathology diagnoses were examined, and their relationship with the surgical strategy was questioned. Results: A total of 2723 patients were included in the study. Of these patients, 2600 (95.5%) were operated under elective, while 123 (4.5%) were operated under emergency conditions. While the surgery was completed laparoscopically in 2685 (98.6%) patients, it was converted to open surgery in 38 (1.4%) patients. Age, gender, the presence of primary gallbladder cancer, acute cholecystitis, and xanthogranulomatous cholecystitis in histopathological examination were found to be independent predictive factors for conversion to open surgery (P < .05). The rate of primary invasive carcinoma in the series was 0.1%. Conclusion: Routine histopathological examination of the gallbladder is important for demonstrating a wide spectrum of pathological changes in this organ. Invasive cancer or precursor lesions can be detected even in patients without any macroscopic abnormality. Histopathological examination also plays a role in determining follow-up, further examination, and treatment modality in addition to the diagnosis in these patients.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Lammert F, Gurusamy K, Ko CW, et al. Gallstones. Nat Rev Dis Primers. 2016;2:16024. [CrossRef]
  • 2. Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver. 2012;6(2):172-187. [CrossRef]
  • 3. Olthof PB, Metman MJH, de Krijger RR, et al. Routine pathology and postoperative follow-up are not cost-effective in cholecystectomy for benign gallbladder disease. World J Surg. 2018;42(10):3165- 3170. [CrossRef]
  • 4. Koppatz H, Nordin A, Scheinin T, Sallinen V. The risk of incidental gallbladder cancer is negligible in macroscopically normal cholecystectomy specimens. HPB (Oxf). 2018;20(5):456-461. [CrossRef]
  • 5. Emmett CD, Barrett P, Gilliam AD, Mitchell AI. Routine versus selective histological examination after cholecystectomy to exclude incidental gallbladder carcinoma. Ann R Coll Surg Engl. 2015;97(7):526-529. [CrossRef]
  • 6. Siddiqui FG, Memon AA, Abro AH, Sasoli NA, Ahmad L. Routine histopathology of gallbladder after elective cholecystectomy for gallstones: waste of resources or a justified act? BMC Surg. 2013;13:26. [CrossRef]
  • 7. Basak F, Hasbahceci M, Canbak T, et al. Incidental findings during routine pathological evaluation of gallbladder specimens: review of 1747 elective laparoscopic cholecystectomy cases. Ann R Coll Surg Engl. 2016;98(4):280-283. [CrossRef]
  • 8. Lundgren L, Muszynska C, Ros A, et al. Are incidental gallbladder cancers missed with a selective approach of gallbladder histology at cholecystectomy? World J Surg. 2018;42(4):1092-1099. [CrossRef]
  • 9. Bolat F, Kayaselçuk F, Nursal TZ, Bal N, Tuncer İ. The correlation of the histopathological findings by increasing the sample size in cholecystectomies. Turk J Pathol. 2007;23:137-142.
  • 10. Cavallaro A, Piccolo G, Di Vita M, et al. Managing the incidentally detected gallbladder cancer: algorithms and controversies. Int J Surg. 2014;12(suppl 2):S108-S119. [CrossRef]
  • 11. Choi KS, Choi SB, Park P, Kim WB, Choi SY. Clinical characteristics of incidental or unsuspected gallbladder cancers diagnosed during or after cholecystectomy: a systematic review and meta-analysis. World J Gastroenterol. 2015;21(4):1315-1323. [CrossRef]
  • 12. Kim SJ, Lee JM, Lee ES, Han JK, Choi BI. Preoperative staging of gallbladder carcinoma using biliary MR imaging. J Magn Reson Imaging. 2015;41(2):314-321. [CrossRef]
  • 13. Yang HK, Lee JM, Yu MH, et al. CT diagnosis of gallbladder adenomyomatosis: importance of enhancing mucosal epithelium, the “cotton ball sign”. Eur Radiol. 2018;28(9):3573-3582. [CrossRef]
  • 14. Krell RW, Wei AC. Gallbladder cancer: surgical management. Chin Clin Oncol. 2019;8(4):36. [CrossRef]
  • 15. Bal MM, Ramadwar M, Deodhar K, Shrikhande S. Pathology of gallbladder carcinoma: current understanding and new perspectives. Pathol Oncol Res. 2015;21(3):509-525. [CrossRef]
  • 16. Kanoh K, Shimura T, Tsutsumi S, et al. Significance of contracted cholecystitis lesions as high risk for gallbladder carcinogenesis. Cancer Lett. 2001;169(1):7-14. [CrossRef]
  • 17. Albores-Saavedra J, Alcántra-Vazquez A, Cruz-Ortiz H, Herrera- Goepfert R. The precursor lesions of invasive gallbladder carcinoma. Hyperplasia, atypical hyperplasia and carcinoma in situ. Cancer. 1980;45(5):919-927. [CrossRef]
  • 18. Duarte I, Llanos O, Domke H, Harz C, Valdivieso V. Metaplasia and precursor lesions of gallbladder carcinoma. Frequency, distribution, and probability of detection in routine histologic samples. Cancer. 1993;72(6):1878-1884. [CrossRef]
  • 19. Maesawa C, Ogasawara S, Yashima-Abo A, et al. Aberrant maspin expression in gallbladder epithelium is associated with intestinal metaplasia in patients with cholelithiasis. J Clin Pathol. 2006;59(3):328-330. [CrossRef]
  • 20. Adsay V, Jang KT, Roa JC, et al. Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases. Am J Surg Pathol. 2012;36(9):1279-1301. [CrossRef]
  • 21. Dilek ON, Karasu S, Dilek FH. Diagnosis and treatment of gallbladder polyps: current perspectives. Euroasian J Hepatogastroenterol. 2019;9(1):40-48. [CrossRef]
  • 22. Kubota K, Bandai Y, Noie T, et al. How should polypoid lesions of the gallbladder be treated in the era of laparoscopic cholecystectomy? Surgery. 1995;117(5):481-487. [CrossRef]
  • 23. Wennmacker SZ, van Dijk AH, Raessens JHJ, et al. Polyp size of 1 cm is insufficient to discriminate neoplastic and non-neoplastic gallbladder polyps. Surg Endosc. 2019;33(5):1564-1571. [CrossRef]
  • 24. Kasle D, Rahnemai-Azar AA, Bibi S, et al. Carcinoma in situ in a 7 mm gallbladder polyp: time to change current practice? World J Gastrointest Endosc. 2015;7(9):912-915. [CrossRef]
  • 25. Yaylak F, Deger A, Ucar BI, et al. Cholesterolosis in routine histopathological examination after cholecystectomy: what should a surgeon behold in the reports? Int J Surg. 2014;12(11):1187-1191. [CrossRef]
  • 26. Kocaöz S, Turan G. Preneoplastic and neoplastic gallbladder lesions detected after cholecystectomy. Prz Gastroenterol. 2019;14(3):193-197. [CrossRef]
  • 27. Lauwers GY, Wahl SJ, Scott GV, DeRoux SJ. Papillary mucinous adenoma arising in adenomyomatous hyperplasia of the gall bladder. J Clin Pathol. 1995;48(10):965-967. [CrossRef]
  • 28. Bolukbasi H, Kara Y. An important gallbladder pathology mimicking gallbladder carcinoma: xanthogranulomatous cholecystitis: a single tertiary center experience. Surg Laparosc Endosc Percutan Tech. 2020;30(3):285-289. [CrossRef]
  • 29. Díaz Alcázar MDM, Cervilla Sáez de Tejada E, Zúñiga de Mora Figueroa B, Roldán Mateo L, Roa Colomo A. Xanthogranulomatous cholecystitis: differential diagnosis between acute cholecystitis and gallbladder cancer. Rev Esp Enferm Dig. 2020;112(1):73-74. [CrossRef]
  • 30. Park JW, Kim KH, Kim SJ, Lee SK. Xanthogranulomatous cholecystitis: is an initial laparoscopic approach feasible? Surg Endosc. 2017;31(12):5289-5294. [CrossRef]
  • 31. Alves Ribeiro M, Petersen da Costa Ferreira C, de Lucia Hernani B, et al. Uncommon site of metastasis from renal cell carcinoma: case report. Int J Surg Case Rep. 2019;56:45-48. [CrossRef]
APA KOZAN R, Özaydın S, Bayhan H, Leventoglu S, Karamercan A, Anadol A, Sare M, AYTAÇ A (2021). Routine Histopathological Examination of the Specimen After Laparoscopic Cholecystectomy: Can We Be Brave Enough to Give Up?. , 218 - 224. 10.5152/tjg.2021.20334
Chicago KOZAN Ramazan,Özaydın Safa,Bayhan Hüseyin,Leventoglu Sezai,Karamercan Ahmet,Anadol Ahmet Ziya,Sare Mustafa,AYTAÇ ABDULKADIR BÜLENT Routine Histopathological Examination of the Specimen After Laparoscopic Cholecystectomy: Can We Be Brave Enough to Give Up?. (2021): 218 - 224. 10.5152/tjg.2021.20334
MLA KOZAN Ramazan,Özaydın Safa,Bayhan Hüseyin,Leventoglu Sezai,Karamercan Ahmet,Anadol Ahmet Ziya,Sare Mustafa,AYTAÇ ABDULKADIR BÜLENT Routine Histopathological Examination of the Specimen After Laparoscopic Cholecystectomy: Can We Be Brave Enough to Give Up?. , 2021, ss.218 - 224. 10.5152/tjg.2021.20334
AMA KOZAN R,Özaydın S,Bayhan H,Leventoglu S,Karamercan A,Anadol A,Sare M,AYTAÇ A Routine Histopathological Examination of the Specimen After Laparoscopic Cholecystectomy: Can We Be Brave Enough to Give Up?. . 2021; 218 - 224. 10.5152/tjg.2021.20334
Vancouver KOZAN R,Özaydın S,Bayhan H,Leventoglu S,Karamercan A,Anadol A,Sare M,AYTAÇ A Routine Histopathological Examination of the Specimen After Laparoscopic Cholecystectomy: Can We Be Brave Enough to Give Up?. . 2021; 218 - 224. 10.5152/tjg.2021.20334
IEEE KOZAN R,Özaydın S,Bayhan H,Leventoglu S,Karamercan A,Anadol A,Sare M,AYTAÇ A "Routine Histopathological Examination of the Specimen After Laparoscopic Cholecystectomy: Can We Be Brave Enough to Give Up?." , ss.218 - 224, 2021. 10.5152/tjg.2021.20334
ISNAD KOZAN, Ramazan vd. "Routine Histopathological Examination of the Specimen After Laparoscopic Cholecystectomy: Can We Be Brave Enough to Give Up?". (2021), 218-224. https://doi.org/10.5152/tjg.2021.20334
APA KOZAN R, Özaydın S, Bayhan H, Leventoglu S, Karamercan A, Anadol A, Sare M, AYTAÇ A (2021). Routine Histopathological Examination of the Specimen After Laparoscopic Cholecystectomy: Can We Be Brave Enough to Give Up?. Turkish Journal of Gastroenterology, 32(2), 218 - 224. 10.5152/tjg.2021.20334
Chicago KOZAN Ramazan,Özaydın Safa,Bayhan Hüseyin,Leventoglu Sezai,Karamercan Ahmet,Anadol Ahmet Ziya,Sare Mustafa,AYTAÇ ABDULKADIR BÜLENT Routine Histopathological Examination of the Specimen After Laparoscopic Cholecystectomy: Can We Be Brave Enough to Give Up?. Turkish Journal of Gastroenterology 32, no.2 (2021): 218 - 224. 10.5152/tjg.2021.20334
MLA KOZAN Ramazan,Özaydın Safa,Bayhan Hüseyin,Leventoglu Sezai,Karamercan Ahmet,Anadol Ahmet Ziya,Sare Mustafa,AYTAÇ ABDULKADIR BÜLENT Routine Histopathological Examination of the Specimen After Laparoscopic Cholecystectomy: Can We Be Brave Enough to Give Up?. Turkish Journal of Gastroenterology, vol.32, no.2, 2021, ss.218 - 224. 10.5152/tjg.2021.20334
AMA KOZAN R,Özaydın S,Bayhan H,Leventoglu S,Karamercan A,Anadol A,Sare M,AYTAÇ A Routine Histopathological Examination of the Specimen After Laparoscopic Cholecystectomy: Can We Be Brave Enough to Give Up?. Turkish Journal of Gastroenterology. 2021; 32(2): 218 - 224. 10.5152/tjg.2021.20334
Vancouver KOZAN R,Özaydın S,Bayhan H,Leventoglu S,Karamercan A,Anadol A,Sare M,AYTAÇ A Routine Histopathological Examination of the Specimen After Laparoscopic Cholecystectomy: Can We Be Brave Enough to Give Up?. Turkish Journal of Gastroenterology. 2021; 32(2): 218 - 224. 10.5152/tjg.2021.20334
IEEE KOZAN R,Özaydın S,Bayhan H,Leventoglu S,Karamercan A,Anadol A,Sare M,AYTAÇ A "Routine Histopathological Examination of the Specimen After Laparoscopic Cholecystectomy: Can We Be Brave Enough to Give Up?." Turkish Journal of Gastroenterology, 32, ss.218 - 224, 2021. 10.5152/tjg.2021.20334
ISNAD KOZAN, Ramazan vd. "Routine Histopathological Examination of the Specimen After Laparoscopic Cholecystectomy: Can We Be Brave Enough to Give Up?". Turkish Journal of Gastroenterology 32/2 (2021), 218-224. https://doi.org/10.5152/tjg.2021.20334